This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Retrospective Observational Analysis of a Cohort With Heart Failure With Preserved Ejection Fraction

Sponsored by Portsmouth Hospitals NHS Trust

About this trial

Last updated 2 years ago

Study ID

262060

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
18 to 95 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 5 years ago

What is this trial about?

Heart failure with preserved ejection fraction (HFpEF) is a complex condition with various causes that is not yet fully understood. Most significantly there is no single method of diagnosing or treating the condition. Recently a novel non-invasive diagnostic criterion to predict the likelihood of HFpEF was proposed called H2FPEF. The main limitation of this study was the use of a single centre population from the Mayo clinic in Rochester, US. Another limitation is that the H2FPEF diagnostic criterion consists of common and often co-existing conditions which could as a result overestimate HFpEF probability. The aim of the investigators is to retrospectively test the H2FPEF criteria on the population at Queen Alexandra Hospital (QAH) in Portsmouth, which is of a lower socio-economic status and greater ethnic diversity. Implications of the proposed project if H2FPEF is proved to be generalizable to the study population is that it can be used within the Trust and rolled out to others. This would allow diagnosis to be made quicker and more cost effectively using echocardiography and without the need for invasive cardiac catheterisation. On the other hand if H2FPEF is found not to be applicable to the population then further research would be required to find the ideal diagnostic tool.

What are the participation requirements?

Yes

Inclusion Criteria

- Age 18-95yrs inclusive

- Currently or previously attended a heart failure clinic with a cardiology consultant at QAH

- Had an echocardiogram, ECG, BNP blood biomarker test in addition to a routine clinical evaluation (including age, weight and number of hypertensive medications) during January 1st 2016 - December 31st 2016.

No

Exclusion Criteria

- Known structural heart disease

- Significant heart valve disease (greater than mild stenosis, greater than moderate regurgitation)

- Pulmonary arterial hypertension

- Constrictive pericarditis

- Pre-existing cardiomyopathy

- Heart transplantation

Locations

Location

Status